Ribupatide
To Compare the Efficacy and Safety of HRS9531 and Placebo in Subjects With Overweight or Obese
Fujian Shengdi Pharmaceutical Co · Phase 3 · Completed · Enrollment 567
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.